Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

34.82
Delayed Data
As of Aug 26
 +0.05 / +0.14%
Today’s Change
28.25
Today|||52-Week Range
37.39
+7.87%
Year-to-Date
The EpiPen Scandal Is Worse Than You Think: What Youre Not Being Told
11:29am / Investing Channel - Paid Partner Content
Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Med...
Aug 26 / MotleyFool.com - Paid Partner Content
Pharmaceuticals are the New Bonds
Aug 26 / GuruFocus News - Paid Partner Content
Tight Trading on Thursday with Stocks Ending Lower
Aug 25 / GuruFocus News - Paid Partner Content
Can Novartis Tide Over the Alcon Crisis?
Aug 26 / GuruFocus News - Paid Partner Content
Pfizer (PFE) Stock Earnings Estimates Raised at Jefferies on $14 Billion Medivation D...
Aug 25 / TheStreet.com - Paid Partner Content
Dow 30 Stock Roundup: Pfizer's Big Buy, Boeing's Big Win
Aug 26 / Zacks.com - Paid Partner Content
Company News for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
3 Top Stocks For Retirees
Aug 26 / MotleyFool.com - Paid Partner Content
Healthcare Drug Pricing a Factor for the Market on Wednesday
Aug 24 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close34.77
Today’s open34.80
Day’s range34.66 - 35.10
Volume18,771,960
Average volume (3 months)24,274,641
Market cap$211.2B
Dividend yield3.45%
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+11.84%
Earnings growth (next 5 years)+6.90%
Revenue growth (last year)-1.52%
P/E ratio30.8
Price/Sales4.13
Price/Book3.32

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.24-0.30%
MRKMerck+0.53+0.85%
AGNPRAAllergan plc+2.01+0.24%
GSKGlaxoSmithKline-0.19-0.43%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.62
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs